# UNCY (Unicycive Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Unicycive Therapeutics, Inc. reported $69.93M in total assets and a net loss of $36.21M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/UNCY
- Markdown: https://convexityos.com/fundamentals/UNCY.md
- SEC CIK: 0001766140
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001766140&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$34.64M | Operating profit |
| Net Income | FY 2025 | -$36.21M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.28 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$29.35M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $58.97M | Total debt: $522K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $675K | $951K | -- | -- |
| Research & Development | $9.12M | $20.01M | $12.90M | $12.44M | $6.08M | $1.01M |
| Selling, General & Admin | -- | -- | -- | $383K | $245K | $58K |
| Total Operating Expenses | $29.52M | $32.12M | $21.45M | $19.00M | $8.98M | $2.02M |
| **Operating Income** | -$29.52M | -$32.12M | -$20.77M | -$18.05M | -$8.98M | -$2.02M |
| **EBITDA** | -$29.48M | -$32.09M | -$20.77M | -$17.62M | -$8.51M | -$1.96M |
| Interest Income | $1.01M | $1.26M | $615K | -- | -- | -- |
| Interest Expense | $71K | $71K | $82K | $6.0K | $628K | $244K |
| **Net Income** | -$26.55M | -$36.73M | -$30.54M | -$18.06M | -$10.02M | -$2.26M |
| Basic EPS | -$1.67 | -$5.65 | -$12.80 | -$12.00 | -$8.60 | -$2.70 |
| **Diluted EPS** | -$1.67 | -$5.65 | -$12.80 | -$12.00 | -$8.60 | -- |
| Basic Shares Outstanding | 15.9M | 6.7M | 2.5M | 1.5M | 1.2M | 850.0K |
| Diluted Shares Outstanding | 15.9M | 6.7M | 2.5M | 1.5M | 1.2M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.25M | $2.79M | $1.61M | $2.25M | $2.96M | $1.75M | $2.17M | $5.29M |
| Total Operating Expenses | $8.84M | $10.14M | $8.44M | $7.22M | $7.34M | $6.96M | $7.99M | $9.26M |
| **Operating Income** | -$8.84M | -$10.14M | -$8.44M | -$7.22M | -$7.34M | -$6.96M | -$7.99M | -$9.26M |
| **EBITDA** | -$8.83M | -$10.13M | -$8.43M | -$7.21M | -$7.33M | -$6.96M | -$7.98M | -$9.25M |
| Interest Income | $503K | $441K | $394K | $351K | $279K | $155K | $226K | $314K |
| Interest Expense | -- | -- | -- | $27K | $15K | $13K | $15K | $20K |
| **Net Income** | -$7.00M | -$1.72M | -$12.82M | -$14.67M | -$6.01M | -$6.45M | $570K | -$21.52M |
| Basic EPS | -$0.25 | -$0.06 | -$0.54 | -- | -$0.33 | -$0.52 | $0.04 | -- |
| **Diluted EPS** | -$0.25 | -$0.06 | -$0.54 | -- | -$0.33 | -$0.52 | -$0.50 | -- |
| Basic Shares Outstanding | 28.3M | 26.9M | 23.9M | -- | 18.1M | 12.3M | 11.7M | -- |
| Diluted Shares Outstanding | 28.3M | 26.9M | 23.9M | -- | 18.1M | 12.3M | 12.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $29.20M | $26.14M | $9.70M | $455K | $16.58M | -- |
| Short-Term Investments | $12.07M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $41.27M | $26.14M | $9.70M | $455K | $16.58M | -- |
| Inventory | -- | -- | -- | $2.19M | $1.83M | -- |
| **Total Current Assets** | $48.96M | $30.95M | $13.40M | $2.64M | $18.41M | $204K |
| Property, Plant & Equipment, Net | $66K | $75K | $26K | $22K | $28K | -- |
| **Total Non-Current Assets** | $174K | $720K | $792K | $174K | $333K | $0 |
| **Total Assets** | $49.13M | $31.67M | $14.19M | $2.82M | $18.74M | $204K |
| Accounts Payable | $383K | $1.06M | $839K | $892K | $742K | $184K |
| Other Current Liabilities | $82K | $92K | $18K | -- | -- | -- |
| **Total Current Liabilities** | $18.94M | $24.12M | $17.53M | $3.28M | $2.10M | $2.88M |
| **Total Non-Current Liabilities** | $0 | $117K | $466K | $0 | $155K | $0 |
| **Total Liabilities** | $18.94M | $24.24M | $18.00M | $3.28M | $2.26M | $2.88M |
| **Total Debt (incl. Leases)** | $117K | $681K | $793K | $155K | $306K | -- |
| Common Stock | $22K | $11K | $35K | $15K | $15K | $9.0K |
| Retained Earnings | -$127.8M | -$101.3M | -$64.54M | -$34.00M | -$15.94M | -$5.92M |
| Accumulated Other Comp. Income | -$1.0K | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $30.20M | $7.43M | -$3.81M | -$466K | $16.48M | -$2.67M |
| Total Equity | $30.20M | $7.43M | -$3.81M | -$466K | $16.48M | -$2.67M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.97M | $44.19M | $37.37M | $29.20M | $42.70M | $22.33M | $19.77M | $26.14M |
| Short-Term Investments | $17.01M | $17.24M | $17.21M | $12.07M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $58.97M | $61.42M | $54.59M | $41.27M | $42.70M | $22.33M | $19.77M | $26.14M |
| **Total Current Assets** | $69.16M | $71.32M | $63.55M | $48.96M | $50.29M | $29.53M | $27.35M | $30.95M |
| Property, Plant & Equipment, Net | $255K | $41K | $48K | $66K | $75K | $83K | $83K | $75K |
| **Total Non-Current Assets** | $774K | $709K | $861K | $174K | $324K | $469K | $601K | $720K |
| **Total Assets** | $69.93M | $72.03M | $64.41M | $49.13M | $50.61M | $30.00M | $27.95M | $31.67M |
| Accounts Payable | $1.03M | $2.23M | $1.14M | $383K | $957K | $775K | $1.40M | $1.06M |
| Other Current Liabilities | $113K | $67K | $126K | $82K | $240K | $67K | $146K | $92K |
| **Total Current Liabilities** | $17.31M | $18.70M | $26.48M | $18.94M | $13.13M | $13.57M | $16.68M | $24.12M |
| **Total Non-Current Liabilities** | $0 | $55K | $217K | $0 | $0 | $0 | $0 | $117K |
| **Total Liabilities** | $17.31M | $18.76M | $26.70M | $18.94M | $13.13M | $13.57M | $16.68M | $24.24M |
| **Total Debt (incl. Leases)** | $522K | $671K | $815K | $117K | $265K | $409K | $548K | $681K |
| Common Stock | $29K | $28K | $25K | $22K | $21K | $122K | $120K | $11K |
| Retained Earnings | -$149.4M | -$142.4M | -$140.6M | -$127.8M | -$113.2M | -$107.1M | -$127.8M | -$101.3M |
| Accumulated Other Comp. Income | -$26K | -$23K | $6.0K | -$1.0K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $52.62M | $53.27M | $37.70M | $30.20M | $37.48M | $16.43M | $11.27M | $7.43M |
| Total Equity | $52.62M | $53.27M | $37.70M | $30.20M | $37.48M | $16.43M | $11.27M | $7.43M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.55M | -$36.73M | -$30.54M | -$18.06M | -$10.02M | -$2.26M |
| Depreciation & Amortization | $34K | $22K | $9.0K | $428K | $468K | $63K |
| Stock-Based Compensation | $2.64M | $2.35M | $1.77M | $1.05M | $966K | $232K |
| **Operating Cash Flow** | -$31.32M | -$28.57M | -$18.28M | -$15.65M | -$5.77M | -$1.46M |
| Capital Expenditure | -$24K | -$72K | -$12K | -$2.0K | -$29K | -- |
| **Free Cash Flow** | -$31.34M | -$28.65M | -$18.30M | -$15.65M | -$5.80M | -- |
| Purchases of Investments | -$12.07M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$12.10M | -$72K | -$12K | -$2.0K | -$29K | -- |
| Common Stock Issued | -- | -- | -- | $11K | -- | -- |
| Dividends Paid | -- | -$1.09M | -$900K | -- | -- | -- |
| **Financing Cash Flow** | $46.47M | $45.09M | $27.54M | -$471K | $22.38M | $1.44M |
| **Net Change in Cash** | $3.06M | $16.44M | $9.25M | -$16.12M | $16.58M | -$15K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.00M | -$1.72M | -$12.82M | -$14.67M | -$6.01M | -$6.45M | $570K | -$21.52M |
| Depreciation & Amortization | $7.0K | $6.0K | $8.0K | $10K | $10K | $6.0K | $8.0K | $7.0K |
| Stock-Based Compensation | $1.80M | $2.88M | $754K | $777K | $730K | $571K | $563K | $582K |
| **Operating Cash Flow** | -$7.25M | -$7.60M | -$6.24M | -$8.03M | -$5.96M | -$8.42M | -$8.90M | -$6.55M |
| Capital Expenditure | -$221K | $1.0K | -$8.0K | $0 | -$2.0K | -$6.0K | -$16K | -$22K |
| **Free Cash Flow** | -$7.47M | -$7.60M | -$6.25M | -$8.03M | -$5.96M | -$8.43M | -$8.92M | -$6.57M |
| Purchases of Investments | -$4.16M | -$3.00M | -$5.15M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $63K | -$23K | -$5.16M | -$12.07M | -$2.0K | -$6.0K | -$16K | -$22K |
| **Financing Cash Flow** | $4.97M | $14.44M | $19.57M | $6.61M | $26.33M | $10.98M | $2.55M | $365K |
| **Net Change in Cash** | -$2.22M | $6.81M | $8.17M | -$13.50M | $20.37M | $2.56M | -$6.37M | -$6.21M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -3077.6% | -1898.2% | -- | -- |
| **Net Profit Margin** | -- | -- | -4525.0% | -1898.8% | -- | -- |
| Return on Equity (ROE) | -87.9% | -494.3% | -- | -- | -60.8% | -- |
| Return on Assets (ROA) | -54.0% | -116.0% | -215.2% | -640.8% | -53.4% | -1109.8% |
| Current Ratio | 2.59x | 1.28x | 0.76x | 0.81x | 8.75x | 0.07x |
| Quick Ratio | 2.18x | 1.08x | 0.55x | 0.14x | 7.88x | -- |
| Debt to Equity | 0.00x | 0.09x | -- | -- | 0.02x | -- |
| **Revenue Growth (YoY)** | -- | -- | -29.0% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -68.8% | -66.1% | -106.0% | -87.9% | -89.1% | -191.7% | -134.8% | -494.3% |
| Return on Assets (ROA) | -51.8% | -48.9% | -62.0% | -54.0% | -66.0% | -105.0% | -54.4% | -116.0% |
| Current Ratio | 4.00x | 3.81x | 2.40x | 2.59x | 3.83x | 2.18x | 1.64x | 1.28x |
| Quick Ratio | 3.41x | 3.28x | 2.06x | 2.18x | 3.25x | 1.65x | 1.19x | 1.08x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.00x | 0.01x | 0.02x | 0.05x | 0.09x |
| **Net Income Growth (YoY)** | -- | -- | -2349.6% | -- | -- | -165.4% | -- | -- |
| EPS Growth (YoY) | -- | -- | -1450.0% | -- | -- | -165.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
